The BTG Cycle Challenge 2013
Colleagues riding 270 miles this weekend to raise money for Leukaemia & Lymphoma Research
London, UK, 3 May 2013: BTG, the specialist healthcare company is delighted to announce the start of the BTG Cycle Challenge which takes place over this weekend. 13 riders from each of our three UK sites will embark on a 270 mile journey which will take them from Protherics UK Ltd in West Wales on Saturday via Biocompatibles UK Ltd in Farnham on Sunday to the finish at BTG’s headquarters in the centre of London on Monday. An additional 4 riders will lend their support by joining the last leg of the challenge on Monday from Reading via Farnham to London.
The riders are raising money for Leukaemia & Lymphoma Research, the only UK charity dedicated to improving the lives of patients with all types of blood cancer, including leukaemia, lymphoma and myeloma. Fundraising is progressing well and team aim to raise £10,000. The team’s fundraising page is located at:https://mydonate.bt.com/fundraisers/btgcharitycyclechallenge2013.
Louise Makin, CEO of BTG commented, “Teamwork is one of our core company values so it’s wonderful to see individuals from each of our three UK sites take the initiative and come together to raise money for such a good cause. I wish the team the very best for the ride and look forward to congratulating them on the completion of the Challenge early next week.”
Ikram Dahman, Fundraising Director at Leukaemia & Lymphoma Research said, “We are delighted to welcome the BTG cyclists to our sports fundraising team, The Unstoppables. Every penny raised by the BTG team for Leukaemia & Lymphoma Research will help us in our mission to beat blood cancer – stopping people from dying and making patients’ lives better. We wish them the very best of luck on their challenge.”
For further information please contact:
Ashley Tapp, Communications Manager
Tel: +44 (0)20 7575 1513; Mobile: +44 (0) 7790 811554
Leukaemia & Lymphoma Research
Callum Mackay, Business Development Manager
Tel: +44 (0)20 7504 2232
BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer, varicose veins and other disorders. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.
Protherics UK Ltd and Biocompatibles UK Ltd are BTG International group companies. BTG and the BTG roundel logo are trademarks of BTG International Ltd and are registered trademarks in the US, EU and certain other territories.
About Leukaemia & Lymphoma Research
Leukaemia & Lymphoma Research is dedicated to saving the lives of blood cancer patients through the promotion and assistance of research into causes, diagnosis and treatment. We are committed to advancing the interests of patients and increasing public understanding of blood cancers. Around 30,000 people of all ages, from children to adults, are diagnosed with blood cancers such as leukaemia, lymphoma and myeloma every year in the UK. We receive no government funding and rely entirely on voluntary support. In the next five years we need to raise £120 million to continue our lifesaving research. Further information, including patient information booklets, is available from www.beatingbloodcancers.org.uk or on Tel: +44 (0) 20 7504 2200.